Reviewing Eagleford Energy (OTCMKTS:GRUSF) & Insulet (NASDAQ:PODD)

Eagleford Energy (OTCMKTS:GRUSFGet Free Report) and Insulet (NASDAQ:PODDGet Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations and institutional ownership.

Institutional and Insider Ownership

9.3% of Eagleford Energy shares are held by institutional investors. 23.2% of Eagleford Energy shares are held by insiders. Comparatively, 0.4% of Insulet shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Eagleford Energy and Insulet”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Eagleford Energy $27.02 million 3.74 -$11.30 million $0.02 24.25
Insulet $2.07 billion 9.61 $418.30 million $3.45 82.01

Insulet has higher revenue and earnings than Eagleford Energy. Eagleford Energy is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Eagleford Energy and Insulet’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Eagleford Energy 31.81% 28.90% 14.38%
Insulet 9.76% 24.36% 10.02%

Analyst Ratings

This is a summary of recent recommendations and price targets for Eagleford Energy and Insulet, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Eagleford Energy 0 0 0 0 0.00
Insulet 0 2 21 1 2.96

Insulet has a consensus price target of $381.75, indicating a potential upside of 34.93%. Given Insulet’s stronger consensus rating and higher possible upside, analysts clearly believe Insulet is more favorable than Eagleford Energy.

Summary

Insulet beats Eagleford Energy on 9 of the 14 factors compared between the two stocks.

About Eagleford Energy

(Get Free Report)

Grown Rogue International Inc., together with its subsidiaries, produces and sells cannabis products in the United States. It offers a range of cultivars for consumers, such as indicas, sativas, and hybrids; strain-specific prepackaged flowers; and pre-roll pack products, as well as provides consulting services. The company sells its products through direct-to-retail delivery and third-party delivery, wholesalers, and processors. Grown Rogue International Inc. is headquartered in Medford, Oregon.

About Insulet

(Get Free Report)

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Receive News & Ratings for Eagleford Energy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eagleford Energy and related companies with MarketBeat.com's FREE daily email newsletter.